Neutralizing response elicited by homologous and heterologous prime booster vaccination against ancestral SARS-CoV-2 B.1, P.1, C.37 and B.1.617.2 variants

Heterologous Covid-19 vaccination strategies arose due to interruption of vaccination programs plus delay and shortage of vaccine supplies. We analysed neutralizing response against ancestral SARS-CoV-2 B.1 and P.1, C.37 and B.1.67.2 variants elicited by 16 homologous and heterologous protocols comb...

Descripción completa

Detalles Bibliográficos
Autores principales: Blanco, Sebastián, Spinsanti, Lorena, Aguilar, Juan Javier, Diaz, Adrián, Beranek, Mauricio, Fernández, Elmer Andrés, Mangeaud, Arnaldo Pedro, Konigheim, Brenda Salomé, Gallego, Sandra Verónica
Formato: Artículo
Lenguaje:Español
Publicado: Elsevier Ltd 2022
Materias:
R Medicina (General)
RB Patología
Acceso en línea:http://pa.bibdigital.ucc.edu.ar/3507/1/A_Blanco_Spinsanti_Aguilar.pdf
Aporte de:
Producción Académica Universidad Católica de Córdoba (UCCor) de Universidad Católica de Córdoba
id I38-R144-3507
record_format dspace
spelling I38-R144-35072025-04-07T19:32:15Z http://pa.bibdigital.ucc.edu.ar/3507/ Neutralizing response elicited by homologous and heterologous prime booster vaccination against ancestral SARS-CoV-2 B.1, P.1, C.37 and B.1.617.2 variants Blanco, Sebastián Spinsanti, Lorena Aguilar, Juan Javier Diaz, Adrián Beranek, Mauricio Fernández, Elmer Andrés Mangeaud, Arnaldo Pedro Konigheim, Brenda Salomé Gallego, Sandra Verónica R Medicina (General) RB Patología Heterologous Covid-19 vaccination strategies arose due to interruption of vaccination programs plus delay and shortage of vaccine supplies. We analysed neutralizing response against ancestral SARS-CoV-2 B.1 and P.1, C.37 and B.1.67.2 variants elicited by 16 homologous and heterologous protocols combining Gam-COVID-Vac, ChAdOx1-S, Ad5-nCorV, BBIBP-CorV and mRNA-1273 vaccines. Homologous mRNA-1273 and heterologous schemes of a non-replicative viral vector/inactivated virus-based vaccine combined with mRNA-1273 induced significantly broader and greater neutralizing antibody-response. Moreover, serum from participants vaccinated with combinations of ChAdOx1-S/Ad5-nCorV and BBIBP-CorV/non-replicative viral vector-based vaccines showed higher or equivalent neutralizing response compared to homologous protocols, pointing them as good alternative platforms. BBIBP-CorV used as second dose exhibited significantly lower neutralizing response compared to other protocols, demonstrating that it should not be recommended as second dose. The information provided herein is valuable to redesign vaccination strategies, especially for low-income countries that still struggle with low percentages of immunized populations and vaccine supply shortage. Elsevier Ltd 2022-11-08 info:eu-repo/semantics/article info:eu-repo/semantics/closedAccess application/pdf spa http://pa.bibdigital.ucc.edu.ar/3507/1/A_Blanco_Spinsanti_Aguilar.pdf Blanco, Sebastián ORCID: https://orcid.org/0000-0001-7832-2833 <https://orcid.org/0000-0001-7832-2833>, Spinsanti, Lorena ORCID: https://orcid.org/0000-0002-0157-4570 <https://orcid.org/0000-0002-0157-4570>, Aguilar, Juan Javier, Diaz, Adrián, Beranek, Mauricio, Fernández, Elmer Andrés, Mangeaud, Arnaldo Pedro ORCID: https://orcid.org/0000-0002-7370-7256 <https://orcid.org/0000-0002-7370-7256>, Konigheim, Brenda Salomé ORCID: https://orcid.org/0000-0003-1724-2156 <https://orcid.org/0000-0003-1724-2156> and Gallego, Sandra Verónica (2022) Neutralizing response elicited by homologous and heterologous prime booster vaccination against ancestral SARS-CoV-2 B.1, P.1, C.37 and B.1.617.2 variants. Vaccine, 40 (47). pp. 6706-6710. ISSN 0264-410X https://www.scopus.com/redirect/linking.uri?targetURL=https%3a%2f%2fdoi.org%2f10.1016%2fj.vaccine.2022.10.021&locationID=1&categoryID=4&eid=2-s2.0-85140788715&issn=0264410X&linkType=ViewAtPublisher&year=2022&origin=recordpage&dig=4a69884ad50ef899c47b6313c4db0671 info:eu-repo/semantics/altIdentifier/doi/10.1016/j.vaccine.2022.10.021
institution Universidad Católica de Córdoba
institution_str I-38
repository_str R-144
collection Producción Académica Universidad Católica de Córdoba (UCCor)
language Español
orig_language_str_mv spa
topic R Medicina (General)
RB Patología
spellingShingle R Medicina (General)
RB Patología
Blanco, Sebastián
Spinsanti, Lorena
Aguilar, Juan Javier
Diaz, Adrián
Beranek, Mauricio
Fernández, Elmer Andrés
Mangeaud, Arnaldo Pedro
Konigheim, Brenda Salomé
Gallego, Sandra Verónica
Neutralizing response elicited by homologous and heterologous prime booster vaccination against ancestral SARS-CoV-2 B.1, P.1, C.37 and B.1.617.2 variants
topic_facet R Medicina (General)
RB Patología
description Heterologous Covid-19 vaccination strategies arose due to interruption of vaccination programs plus delay and shortage of vaccine supplies. We analysed neutralizing response against ancestral SARS-CoV-2 B.1 and P.1, C.37 and B.1.67.2 variants elicited by 16 homologous and heterologous protocols combining Gam-COVID-Vac, ChAdOx1-S, Ad5-nCorV, BBIBP-CorV and mRNA-1273 vaccines. Homologous mRNA-1273 and heterologous schemes of a non-replicative viral vector/inactivated virus-based vaccine combined with mRNA-1273 induced significantly broader and greater neutralizing antibody-response. Moreover, serum from participants vaccinated with combinations of ChAdOx1-S/Ad5-nCorV and BBIBP-CorV/non-replicative viral vector-based vaccines showed higher or equivalent neutralizing response compared to homologous protocols, pointing them as good alternative platforms. BBIBP-CorV used as second dose exhibited significantly lower neutralizing response compared to other protocols, demonstrating that it should not be recommended as second dose. The information provided herein is valuable to redesign vaccination strategies, especially for low-income countries that still struggle with low percentages of immunized populations and vaccine supply shortage.
format Artículo
author Blanco, Sebastián
Spinsanti, Lorena
Aguilar, Juan Javier
Diaz, Adrián
Beranek, Mauricio
Fernández, Elmer Andrés
Mangeaud, Arnaldo Pedro
Konigheim, Brenda Salomé
Gallego, Sandra Verónica
author_facet Blanco, Sebastián
Spinsanti, Lorena
Aguilar, Juan Javier
Diaz, Adrián
Beranek, Mauricio
Fernández, Elmer Andrés
Mangeaud, Arnaldo Pedro
Konigheim, Brenda Salomé
Gallego, Sandra Verónica
author_sort Blanco, Sebastián
title Neutralizing response elicited by homologous and heterologous prime booster vaccination against ancestral SARS-CoV-2 B.1, P.1, C.37 and B.1.617.2 variants
title_short Neutralizing response elicited by homologous and heterologous prime booster vaccination against ancestral SARS-CoV-2 B.1, P.1, C.37 and B.1.617.2 variants
title_full Neutralizing response elicited by homologous and heterologous prime booster vaccination against ancestral SARS-CoV-2 B.1, P.1, C.37 and B.1.617.2 variants
title_fullStr Neutralizing response elicited by homologous and heterologous prime booster vaccination against ancestral SARS-CoV-2 B.1, P.1, C.37 and B.1.617.2 variants
title_full_unstemmed Neutralizing response elicited by homologous and heterologous prime booster vaccination against ancestral SARS-CoV-2 B.1, P.1, C.37 and B.1.617.2 variants
title_sort neutralizing response elicited by homologous and heterologous prime booster vaccination against ancestral sars-cov-2 b.1, p.1, c.37 and b.1.617.2 variants
publisher Elsevier Ltd
publishDate 2022
url http://pa.bibdigital.ucc.edu.ar/3507/1/A_Blanco_Spinsanti_Aguilar.pdf
work_keys_str_mv AT blancosebastian neutralizingresponseelicitedbyhomologousandheterologousprimeboostervaccinationagainstancestralsarscov2b1p1c37andb16172variants
AT spinsantilorena neutralizingresponseelicitedbyhomologousandheterologousprimeboostervaccinationagainstancestralsarscov2b1p1c37andb16172variants
AT aguilarjuanjavier neutralizingresponseelicitedbyhomologousandheterologousprimeboostervaccinationagainstancestralsarscov2b1p1c37andb16172variants
AT diazadrian neutralizingresponseelicitedbyhomologousandheterologousprimeboostervaccinationagainstancestralsarscov2b1p1c37andb16172variants
AT beranekmauricio neutralizingresponseelicitedbyhomologousandheterologousprimeboostervaccinationagainstancestralsarscov2b1p1c37andb16172variants
AT fernandezelmerandres neutralizingresponseelicitedbyhomologousandheterologousprimeboostervaccinationagainstancestralsarscov2b1p1c37andb16172variants
AT mangeaudarnaldopedro neutralizingresponseelicitedbyhomologousandheterologousprimeboostervaccinationagainstancestralsarscov2b1p1c37andb16172variants
AT konigheimbrendasalome neutralizingresponseelicitedbyhomologousandheterologousprimeboostervaccinationagainstancestralsarscov2b1p1c37andb16172variants
AT gallegosandraveronica neutralizingresponseelicitedbyhomologousandheterologousprimeboostervaccinationagainstancestralsarscov2b1p1c37andb16172variants
_version_ 1832592353408319488

Ejemplares similares